Overview

Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult

Status:
NOT_YET_RECRUITING

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine if intranasal dexmedetomidine could be an alternative to the current standard of care (injectable benzodiazepines or antipsychotics) for sedation prior to computerized tomography (CT) or magnetic resonance imaging (MRI) in those greater than or equal to 65 years of age (older adults) that are seen in the Emergency Department (ED).

Phase:

PHASE3

Details

Lead Sponsor:

State University of New York - Upstate Medical University

Treatments:

Dexmedetomidine
Haloperidol
Lorazepam